News & Views
Optimising Supply Chain for Cellular Platform
Oct 23 2019 Read 1092 Times
Cell and gene therapy supply tracking and orchestration systems software developer TrakCel and CDMO WuXi AppTec Advanced Therapies, have signed a collaborative agreement to accelerate the seamless delivery of advanced therapy treatments to mutual customers.
The two companies will leverage configured manufacturing module in TrakCel’s software, based around WuXi’s current standard operating procedures and preferred workflows. The design of this module will be based on the companies’ long and extensive working relationship. WuXi AppTec Advanced Therapies was the first CDMO to use Cardiff-based TrakCel’s software and its Philadelphia, PA site currently has a greater number of users than any other facility in the supply chain. The resultant pre-built manufacturing module will shorten the time and costs associated with deploying an end-to-end solution to both companies’ mutual clients.
“As one of the first CDMOs to use TrakCel’s software and the supply chain partner with more users than any other facility, WuXi AppTec Advanced Therapies is well placed to collaborate with TrakCel to identify a more efficient way of working together. It is the latest development in TrakCel’s formation of an international partner ecosystem of connected and complementary cell and gene therapy service providers. This partner ecosystem as a result now includes a commercial scale, third party manufacturing company,” said Ravi Nalliah, CEO, TrakCel. “The TrakCel partnership with WuXi AppTec Advanced Therapies will enable both companies to move towards increased standardization and improved delivery of these innovative treatments to patients around the world.”
“We are pleased to establish a collaborative agreement with TrakCel to support customers that seek to promote streamlining personalized therapies from specimen connections to manufacturing,” said Felix Hsu, Senior Vice President and Global Head of WuXi AppTec Advanced Therapies. “With our leading integrated manufacturing and testing services, we believe we can bring even more speed, reliability and security to an already complex manufacturing and supply chain. We are committed to helping our partners deliver more innovative therapies to patients and the market sooner.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Chromatography - The Purification of Crown Ether Samples by a Quaternary Solvent Flash Chromatography System - New Wettable Phase Thrives in Water - Reduced Surface Activity...
View all digital editions
Feb 26 2020 Guanghzou, China
Mar 01 2020 Chicago, IK, USA
Mar 04 2020 Beijing, China
Mar 05 2020 New Delhi, India
Mar 11 2020 Guangzhou, China